BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/23/2016 9:07:00 AM | Browse: 1040 | Download: 2612
Publication Name World Journal of Pharmacology
Manuscript ID 22810
Country United States
ISSN 2220-3192 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pharmacology & Pharmacy
Manuscript Type Review
Article Title Novel strategies for the treatment of diabetic macular edema
Manuscript Source Invited Manuscript
All Author List Hoang M Trinh, Mary Joseph, Kishore Cholkar, Dhananjay Pal and Ashim K Mitra
Funding Agency and Grant Number
Corresponding Author Ashim K Mitra, PhD, Division of Phar­maceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, 2464 Charlotte Street, Kansas City, MO 64108, United States. mitraa@umkc.edu
Key Words Diabetic macular edema; Photocoagulation; Retinopathy; Biologics; Vitrectomy; Corticosteroids; Nanoformulations; Laser
Core Tip Macular edema such as diabetic macular edema (DME) and diabetic retinopathy are devastating back-of-the-eye retinal diseases leading to loss of vision. The standard treatments of DME include laser photocoagulation, vitrectomy, intravitreal injections of anti-vascular endo-thelial growth factor biologics and steroids. In this article we have provided an overview of several emerging novel strategies including nanotechnology based drug delivery approacher for posterior ocular drug delivery and treatment with emphasis on DME.
Publish Date 2016-03-04 15:35
Citation Trinh HM, Joseph M, Cholkar K, Pal D, Mitra AK. Novel strategies for the treatment of diabetic macular edema. World J Pharmacol 2016; 5(1): 1-14
URL http://www.wjgnet.com/2220-3192/full/v5/i1/1.htm
DOI http://dx.doi.org/10.5497/wjp.v5.i1.1
Full Article (PDF) WJP-5-1.pdf
Full Article (Word) WJP-5-1.doc